Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 1718655 | HLA (HLA) | cadaver | NA | NA | NA | unclassified | |
| application of this approach to the successful transplantation of highly immunized patients using hla disparate cadaver renal allografts supports the contentions advanced within this article. | |||||||
| 1727521 | HLA-B (HLA-B) | transplantation | NA | NA | NA | unclassified | |
| #NAME? | |||||||
| 1727521 | HLA-A (HLA-A) | transplantation | NA | NA | NA | unclassified | |
| #NAME? | |||||||
| 1727546 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| of the 52 patients who both entered remission and had an hla match, 30 underwent transplantation while they were in first remission. | |||||||
| 1733639 | HLA-A*02 | transplantation | NA | zidovudine | NA | unclassified | |
| patients were selected for expression of hla-a2 and/or hla-a3 class i transplantation antigen. | |||||||
| 1733639 | HLA-A*03 | transplantation | NA | zidovudine | NA | unclassified | |
| patients were selected for expression of hla-a2 and/or hla-a3 class i transplantation antigen. | |||||||
| 1786062 | HLA-DR6 (BROAD ANTIGEN) | transplantation | NA | NA | NA | positive+negation | |
| there were no significant differences between the three groups in the distribution of hla mismatching (a, b and dr), time interval between the last bt and transplantation, dr6 recipient phenotype, or nonimmunological failures. | |||||||
| 1818544 | HLA IDENTICAL (HLA-IDENTICAL) | prednisolone | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 1818544 | HLA IDENTICAL (HLA-IDENTICAL) | prednisolone | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 1818544 | HLA IDENTICAL (HLA-IDENTICAL) | prednisolone | NA | methotrexate | NA | unclassified | |
| NA | |||||||
Copyright 2024